British Peripheral Nerve Society

This meeting is open to BPNS members and other professionals working in relevant areas, but not to patients or members of the general public without advance permission.

BPNS Teaching Course on Peripheral Neuropathy 2021

Start Date

End Date

Thursday 18 Mar 2021 09:30 AM

Thursday 18 Mar 2021 13:00 PM

Location

Zoom meeting

Details

This teaching course is aimed primarily at registrars in neurology and clinical neurophysiology, but in providing an update on clinical diagnosis and management will also be of value to consultant neurologists and neurophysiologists, general physicians, and any professional seeing patients with peripheral neuropathy. Similar to previous BPNS Teaching Courses, this half day event will include comprehensive lectures on the most important clinical topics in peripheral nerve disease, but is shorter and on Zoom in response to the current COVID-19 pandemic. Speakers are leading UK experts in their fields. Don't miss this opportunity to hear them all together.

Programme (can change before the event)

Date	Time	Type		Presenter
Thu 18 Mar 2021	09:25	Lecture	Welcome and introduction	Dr Rob Hadden
Thu 18 Mar 2021	09:30	Lecture	How to assess a neuropathy	Prof Lionel Ginsberg
Thu 18 Mar 2021	10:00	Lecture	Working with neurophysiology	Dr David Allen
Thu 18 Mar 2021	10:30	Lecture	Vasculitic neuropathy (including nerve biopsy)	Dr Rob Hadden
Thu 18 Mar 2021	11:00	Refreshment	Comfort break
Thu 18 Mar 2021	11:15	Lecture	Small fibre neuropathy	Dr Mohamed Mahdi-Rogers
Thu 18 Mar 2021	11:45	Lecture	CIDP	Prof Yusuf Rajabally
Thu 18 Mar 2021	12:15	Lecture	Inherited neuropathy	Dr Katie Brennan
Thu 18 Mar 2021	12:45	Close

Lost driving licence

Jiten Mistry misplaced his driving licence at the Belfast meeting. If anyone picked it up, please could they contact him at jitenmistry@nhs.net.

Queen Square Annual Update in Neuromuscular Disorders

This course will be held from Wednesday 13th May to Friday 15th May in the Clinical Neuroscience Lecture Theatre, Lower ground, 33 Queen Square, London WC1N 3BG

DETAILS/REGISTRATION

Brain Fellowships

Applications are invited for 1 year fellowships funded by the Guarantors of Brain. These fellowships provide bridging salary support to early career clinicians based in the UK prior to obtaining a research fellowship. Further details can be found HERE

New NHSE commissioning policies for rituximab and IVIg

We are pleased to announce that, largely due to the efforts of our president Prof Lunn, rituximab is now approved for treatment of IgM paraproteinaemic demyelinating peripheral neuropathy (anti-MAG phenotype, with or without anti-MAG antibodies): 1910-rituximab-for-treatment-of-PDPN-policy-v2.pdf (england.nhs.uk). Whilst we have hitherto been able to treat some patients with rituximab by sending them to a haematologist, this was not possible if the bone marrow showed insufficient evidence of underlying lymphoplasmacytic lymphoma. These patients can now be treated, regardless of bone marrow result, either by you or by your friendly haematologist, under the new commissioning guidance.
Also thanks to Prof Lunn (alongside non-neurology colleagues), the updated IVIg commissioning policy is now available: Commissioning-Criteria-Policy-for-the-use-of-Ig-Version-Finala.pdf (mdsas.com). Newly commissioned diagnoses of relevance to peripheral nerve now include acute autoimmune autonomic ganglionopathy, and neuromyotonia.
Finally, with thanks largely to the efforts of Dr Rinaldi in Oxford, rituximab can now be used for the treatment of autoimmune nodopathies (with nodal/paranodal antibodies): NHS England » Rituximab therapy for the treatment of nodal/paranodal antibody positive inflammatory/autoimmune neuropathy in adults and postpubescent children.

More news »

Meetings

Lost driving licence

Queen Square Annual Update in Neuromuscular Disorders

Brain Fellowships

New NHSE commissioning policies for rituximab and IVIg